Letter to the Editor: Salidroside in ulcerative colitis - neuroimmune regulatory mechanisms and clinical translation prospects

doi:10.3748/wjg.123972

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 42

This Article

(3)

(4)

(0)

(26)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correspondence

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Nov 14, 2026; 32(42): 123972
Published online Nov 14, 2026. doi: 10.3748/wjg.123972

Open in New Tab Full Size Figure Download Figure

Figure 1 Schematic summary of salidroside: Anti-ulcerative colitis mechanisms, translational barriers, and pharmacokinetic-based colon-targeted delivery strategies. UC: Ulcerative colitis; GFAP: Glial fibrillary acidic protein; S100B: S100 calciumbinding protein B; IL-1β: Interleukin-1β; TNF-α: Tumor necrosis factor α; IL-6: Interleukin-6.

Citation: Zhou YF, Yan JW, Tang FS. Letter to the Editor: Salidroside in ulcerative colitis - neuroimmune regulatory mechanisms and clinical translation prospects. World J Gastroenterol 2026; 32(42): 123972
URL: https://www.wjgnet.com/1007-9327/full/v32/i42/123972.htm
DOI: https://dx.doi.org/10.3748/wjg.123972

Zhou YF, Yan JW, Tang FS. Letter to the Editor: Salidroside in ulcerative colitis - neuroimmune regulatory mechanisms and clinical translation prospects. World J Gastroenterol 2026; 32(42): 123972 [DOI: 10.3748/wjg.123972]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.